Safety in Lactation: Drugs for the relief of soft-tissue inflammation and topical pain relief

28 October 2020Topical formulations of non-steroidal anti-inflammatories (NSAIDS) and capsaicin produce low systemic levels in the mother. Although there is no direct evidence, subsequent milk levels are…

Safety in Lactation: Non-steroidal anti-inflammatory drugs

23 September 2020There is very limited information on the use of NSAIDs during breastfeeding; ibuprofen and diclofenac are the preferred choices due to their extensive safe use…
Search Articles

Medicine Compliance Aid Stability

genericActavis UK Ltd

Actavis UK Ltd
Capsules 10mg, 20mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from light.
12 February 2020

FeldenePfizer Ltd

Pfizer Ltd
Capsules 10mg, 20mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
Airtight container
Protect from light
Protect from light in airtight container.
12 February 2020

Feldene MeltPfizer Ltd

Pfizer Ltd
Feldene Melt
Tablets 20mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
This is a fast dissolving tablet form which is moisture sensitive.
20 September 2012

Lactation Safety Information

Ibuprofen, Diclofenac
Limited published evidence of safety
Very long half-life increases risk of accumulation in breastfed infants
22 September 2020


Negligible milk levels anticipated as systemic absorption from topical formulations is low
Follow normal precautions for topical medicines (see summary)
22 September 2020